1
2
Certificat ion Commission for Drug & Alcohol Program Professionals
Commission Launches New Member Features
Expert Help Forum, Desk Reference and “On Board” Button
As part of CCDAPP’s commitment to enhancing the benefits
of being a Certified Drug and Alcohol Program Professional,
the commission recently launched three new features to
include an online forum, study guide and an innovative way
to demonstrate your credential.
No Man is an Island Certification-holders have extensive industry knowledge
The following individuals
have recently earned initial
certification or renewed
certification!
Newly Certified:
and many years of experience, yet it’s unlikely that any one individual would be Roxanne Lepre, CSAPA
willing to state that they are adept at every aspect of our industry. However,
collectively our CCDAPP certification holders offer hundreds of years of practical
Renewed Certification:
application and expertise in all facets of the drug and alcohol testing industry.
The CCDAPP Expert Help Forum is designed to open dialogue between members Valerie Fernandez, CSAPA
enabling us to share our strengths with one another as well as combat the Shelia Guzman, CSAPA
copious amount of inaccurate information found on the Internet. Please visit
http://www.ccdapp.org/expert-help to register for the forum. You will receive a Cleve Miller, CSAPA
confirmation email once your account is activated.
Eva Ojeda, CSAPA
At Your Fingertips Regulations, reference links and more have been
Linda Richardson, CSAPA
compiled and organized in the CCDAPP Study Guide and Desk Reference Manual
which is now available on our website as a free download for all CCDAPP
certification holders and approved applicants preparing for their exam. Please
email CCDAPP’s Executive Director, Jennifer, to receive your password.
[email protected]
Continued on Page 3
Upcoming Industry Events & Training Opportunities
§
12th Annual FTA Drug and Alcohol Program National Conference April 18-20, 2017, New Orleans, LA
§
DATIA Annual Conference May 16-18, 2017, Orlando, FL
§
USDOT’s Transportation Safety Institute Substance Abuse Management and Program Compliance;
Classes available in Kentucky, South Dakota, California and Maryland, May through August. Visit the
TSI website for further detail: https://tsi-dot.csod.com/LMS/catalog/Welcome.aspx?tab_page_id=67&tab_id=20000325
OSHA Publishes New Regulations
“B la nket ” po st -accid ent test in g
no w p ro hib it ed
Have you or your clients faced any challenges
as a result of this new law?
Join the discussion on our expert-help forum:
http://www.ccdapp.org/expert-help
In May 2016, the Occupational Safety and Health
Administration (OSHA) published new regulations
regarding the tracking of workplace injuries (81 FR
29624, 5/12/16). The preamble to the regulation
notified employers that “blanket” post-accident drug
and alcohol testing would no longer be permitted.
This means that employer policies can no longer
state that post-accident drug testing will occur any
time there is an injury requiring medical treatment
away from the scene of accident or a particular dollar
amount of damage associated with the accident.
The potential civil penalty (fine) for violations is
$12,471.
The implementation date of the regulation was
delayed twice as a court challenge progressed. On
November 28, 2016 the Federal judge declined to
allow an injunction, and the regulation was
implemented on December 1, 2016.
Click here for the guidance published by OSHA:
https://www.osha.gov/recordkeeping/finalrule/interp_
recordkeeping_101816.html
Benefits of CCDAPP Corporate Sponsorship
Our commission is a non-profit organization striving to
enhance and promote the level of professional
knowledge of individuals providing drug and alcohol
testing services. Corporate leaders who recognize the
importance of “raising the bar” within our industry can
demonstrate their commitment through sponsorship
opportunities. Some of the benefits of becoming a
CCDAPP Corporate Sponsor include: placement of
your corporate logo on the CCDAPP website and in our
quarterly newsletters as well as the opportunity to
author spotlight articles for publication in the
newsletters.
For further information regarding
sponsorship, please email CCDAPP’s Executive
Director, Jennifer Peacock: [email protected]
2
Oh the joys of prepping for an audit!
Pictured: Diane Northrop
Dallas Area Rapid Transit
Continued from page 1.
Button-up CCDAPP has developed a new means of identifying that a certified individual is “on board” within
your organization. Logos of varying sizes can be added to websites, email signatures and printed material to
demonstrate an employer’s commitment to hiring and retaining individuals holding the highest level of
certification available within our industry. To obtain the new logo “buttons” for CSAPA and CDAPA certification
holders, visit: http://www.ccdapp.org/csapa-on-board
DOT Published Notice of Proposed Rule Making (NPRM)
On January 23, 2017 the DOT published an NPRM that would add four
opioids to the drug-testing panel and update several testing program
provisions. While the addition of hydrocodone, hydromorphone,
oxycodone and oxymorphone to the testing panel has been
anticipated for quite some time, but a few of the other program
provisions contained within the NPRM may not have been on our
radar:
•
•
•
•
•
Removal of the requirement for employers and C/TPAs to submit blind
specimens to the labs
Requirement for collectors, MROs, STTs, BATs and SAPs to subscribe to the
DOT’s list-serve
Removal of the list of approved SAP certification organizations from Part 40 (list
will be maintained on DOT’s website)
Addressing what a collector must do when a specimen is questionable and the
donor is unable to provide a second specimen
Prohibiting service agents from using the DOT logo and branding to represent
endorsement from the agency
View the full NPRM here:
https://www.gpo.gov/fdsys/pkg/FR-2017-01-23/pdf/2017-01131.pdf
3
A new specimen for drug testing?
Don’t hold your breath!
In January of 2015, The Journal of Chromatography B published the findings of researchers from
the Department of Laboratory Medicine at the Karolinska Institute, Sweden, who had developed
and validated drug testing using exhaled breath.
The principle behind the breath test is that aerosol particles become contaminated with the drugs
from the fluid lining the airways as they are exhaled. These aerosol particles are then collected
onto a filter by a sampling device. The filter containing the particles is then used for testing in the
laboratory by mass spectrometry.
The researchers tested and validated this new method in routine drug testing. They used a total of
1096 samples over a period of 12 months for detection of amphetamine, methamphetamine, 6acetylmorphine, morphine, benzoylecgonine, diazepam, oxazepam, and tetrahydrocannabinol.
The study describes the fully validated method of drug testing and further applies it to routine
measurement on samples that were sent for drug testing. The study also reports for the first time
on the levels of drug present in 39 positive samples derived from breath testing.
The authors report that this method of breath testing has potential for a wide variety of uses,
ranging from clinical applications where urine sampling is more difficult, and compliance testing
during drug addiction treatment, criminal justice applications, workplace drug testing, and accident
investigations. The researchers are also planning to develop a test for therapeutic drug use by
exhaled breath; testing for this is currently underway. Those interested in learning more may
purchase and download the complete study:
http://www.sciencedirect.com/science/article/pii/S1570023215000720
What are your thoughts on the potential use of breath specimens for drug testing?
Start a discussion on our expert-help forum: http://www.ccdapp.org/expert-help
4
CCDAPP Newsletter Q1/2017
Editor and Contributor: Diana Byrnes, CSAPA
Editorial Review: Jana Wolfgang, CSAPA; Jennifer Peacock, Exec. Director
Please direct comment to: [email protected]
CCDAPP Officers:
Robi Bolton, CSAPA, President
Diana Byrnes, CSAPA, Vice-President
Jana Wolfgang, CSAPA, Secretary
Diane Northrop, CSAPA, Treasurer
CCDAPP Commissioners:
Mary Brown-Ybos, CSAPA
Cindy Decker, CSAPA
Dr. Martin Duke, MRO
Regina Doural, CSAPA
Dennis Kerns, CSAPA
Venus Mills, CSAPA
Dr. Richard Plut
Tom Pool, CSAPA
Brandie Reid, CSAPA
Jeff Sims, CSAPA
Helen White, CSAPA
CCDAPP is grateful for the sponsorship our commission
receives. If your organization is interested in learning more
about the benefits of becoming a CCDAPP sponsor, please
email Jennifer Peacock: [email protected]